Matthias Kraemer | Head of Media Relations
Overview metropolitan area
Unrestricted © Siemens Healthcare GmbH, 2015
This document contains statements related to our future business and financial performance and future events or developments involving Siemens that may constitute forward-looking statements. These statements may be identified by words such as 'expect', 'look forward to', 'anticipate', 'intend', 'plan', 'believe', 'seek', 'estimate', 'will', 'project' or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to shareholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements are based on the current expectations and certain assumptions of Siemens' management, of which many are beyond Siemens' control. These are subject to a number of risks, uncertainties and factors, including, but not limited to those described in disclosures, in particular in the chapter Risks in the Annual Report. Should one or more of these risks or uncertainties materialize, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of Siemens may (negatively or positively) vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Siemens neither intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.
This document includes - in IFRS not clearly defined - supplemental financial measures that are or may be non-GAAP financial measures. These supplemental financial measures should not be viewed in isolation or as alternatives to measures of Siemens' net assets and financial positions or results of operations as presented in accordance with IFRS in its Consolidated Financial Statements. Other companies that report or describe similarly titled financial measures may calculate them differently.
Due to rounding, numbers presented throughout this and other documents may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures.
Approximately 60,000 employees in Bavaria, thereof approx. 44,630 in the metropolitan area
Siemens AG as the major employer
in the metropolitan area
Employees
Amberg 4,237
Bamberg 359
Bayreuth 69
Erlangen 23,723
Forchheim 2,075
Fürth 2,384
Kemnath 1,050
Nürnberg 10,582
As of September 30, 2014
Approximately
10,000 employeesin the metropolitan area
Healthcare Building
in Henkestraße 127, 1965
1886 Vereinigte physikalisch-mechanische Werkstätten von Reiniger, Gebbert & Schall (RGS) was founded in Erlangen
1925 RGS was taken over by Siemens & Halske AG (S&H) A joint distribution company is established for medical technology products
1932-33 RGS and its subsidiaries merge with the medical technology division of S&H to form Siemens-Reiniger-Werke AG (SRW)
1947 SRW headquarters is relocated from Berlin to Erlangen
1966 SRW is absorbed by the newly founded Siemens AG and renamed 'Wernerwerk für medizinische Technik'
1969 Siemens AG is reorganized and the corporate division 'Medical Engineering Group' is formed
2001 The corporate division is renamed 'Siemens Medical Solutions'
Acquisition of Bayer Diagnostics, Diagnostic Products Corporation (DPC) and DadeBehring; Siemens Medical Solutions Diagnostics founded
2008 The unit is renamed 'Siemens Healthcare', one of three (later four) Sectors of Siemens AG
2014 Resolution of the Sectors on Siemens AG level. Siemens Healthcare is separately managed under the Siemens umbrella
2015 Separation of Siemens Healthcare's business activities into legal entities under the Siemens umbrella; foundation of Siemens Healthcare GmbH in Germany
Unrestricted © Siemens Healthcare GmbH, 2015
Page 4
Erlangen, September 29, 2015
Matthias Kraemer | Healthcare
Siemens in the Medical Valley Europäische Metropolregion Nürnberg e.V.One of the leading international medical technology clusters
More than 170 key players from business, science, healthcare and politics have joined together to pool their resources as a cluster and to create synergies
Competitive advantages and growth opportunities
Focus
Innovative diagnostic and therapeutic procedures
Solutions for independent living at home - even in old age
Solutions for health promotion and prevention
Approaches to ensure the financial sustainability of healthcare systems
Development of P4 medicine (preventive, predictive, participatory, personalised)
Goal
Develop and market effective solutions tailored to suit global market demands
Source: http://en.medical-valley-emn.de/node/26
Unrestricted © Siemens Healthcare GmbH, 2015
More than 500 companies
are active in medical technology
More than 65 hospitals coupled with a strong outpatient sector provide first-class healthcare
Over 850.000 inpatients are treated on the Medical Valley each year
More than 80 institutes at universities and universities of applied sciences research and teach with
a focus on medical technology
Page 5
Erlangen, September 29, 2015
Matthias Kraemer | Healthcare
1946
1959
1973
1983
Two physicists independently discovered the principle of magnetic resonance:
Felix Bloch and Edward Mills Purcell - They laid the technical foundations for magnetic resonance imaging (Nobel Prize in Physics in1952)
Siemens used magnetic resonance imaging to study plastics in a special research lab
Modern MRI technology is considered to have been born: Chemist Paul C. Lauterbur and Physicist Sir Peter Mansfield were the first to make it possible to visualize
a fluid-filled object (Nobel Prize in Medicine in 2003)
Siemens was the first company in the world to install a commercial magnetic resonance imaging system for clinical applications, the Magnetom.
During whole-body scanning, it was able to visualize structures smaller than two millimeters in an image section with a diameter of 50 centimeters
First MR research laboratory 1979 made of wood
2003
2010
Total imaging matrix 'Tim' technology with high frequency coils.
Tim made it possible to produce images of the entire body in a single pass
Biograph mMR was the first system to bring together all the benefits of MRI and positron emission tomography (PET) technology in one
Princeton, US
SCR
World Class in Algorithm Development
Oxford, UK
SMT World Leading Magnet Development
Joinville, Brazil Healthcare Manu- facturing Plant (MR, CT, XP)
Additional Siemens MR Development and Manufacturing Sites
Erlangen, Germany MR Head- quarters
Local Siemens MR Collaboration Scientists Hub
Bangalore, India Corporate Technology World Class in
SW Development
Shenzhen, China
SSMR
HQ Development and Manufacturing
Erlangen was the birthplace of magnetic resonance imaging at Siemens
Today it is home to the world's most advanced production site for MRI systems
The facility was built in 1999 and has been
expanded on a regular basis since then
It combines production, research, development, marketing, and logistics in a single campus
The Siemens research lab operates almost 30 fully functional MRI systems
Over 10,000 visitors and customers visit the site annually
distributed by |